0001104659-19-005906.txt : 20190205 0001104659-19-005906.hdr.sgml : 20190205 20190205193900 ACCESSION NUMBER: 0001104659-19-005906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190201 FILED AS OF DATE: 20190205 DATE AS OF CHANGE: 20190205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Read Simon CENTRAL INDEX KEY: 0001688199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37926 FILM NUMBER: 19569518 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE STREET 2: C/O RA PHARMACEUTICALS, INC. CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ra Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001481512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262908274 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 401-4060 MAIL ADDRESS: STREET 1: 87 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 a4.xml 4 X0306 4 2019-02-01 0 0001481512 Ra Pharmaceuticals, Inc. RARX 0001688199 Read Simon C/O RA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE BOSTON MA 02140 0 1 0 0 Chief Scientific Officer COMMON STOCK 2019-02-01 4 M 0 9167 A 9167 D COMMON STOCK 2019-02-01 4 F 0 2933 21.00 D 6234 D Options to Purchase Common Stock 21.00 2019-02-01 4 A 0 107000 0 A 2029-02-01 Common Stock 107000 107000 D Restricted Stock Units 2019-02-01 4 M 0 9167 0 D Common Stock 9167 18333 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These stock options vest in 48 equal monthly installments on each monthly anniversary following February 1, 2019, the grant date. On February 1, 2018, the reporting person was granted 27,500 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Not applicable. /s/ David Lubner, Attorney-in-Fact for Simon Read 2019-02-05